Skip Navigation

Philips Respironics issued a recall for some CPAP and BiLevel PAP devices and mechanical ventilators. Learn more.

 

COVID-19: We are vaccinating patients ages 12+. Learn more:

Vaccines | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker | Email Alerts

Jonathan Schneck, M.D., Ph.D.

Headshot of Jonathan Schneck
  • Professor of Pathology

Research Interests

Immunology

Background

Dr. Jonathan Schneck is a professor of pathology, medicine and oncology at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. His research focuses on T cell immunology.

His team pioneered the development of artificial white blood cells, called artificial antigen-presenting cells (aAPCs), which show promise in training animals' immune systems to fight diseases such as cancer. Using nano-aAPCs, his team recently trained the immune systems of mice to fight melanoma.

His lab’s current projects include studying the biophysical, genetic and environmental control of T cell receptor organization.

Dr. Schneck received his undergraduate degree from Yeshiva University. He earned his M.D.-Ph.D. in immunology from the Albert Einstein College of Medicine. After completing his degree, he trained in pediatrics at the Children's Hospital National Medical Center in Washington, D.C. From there he worked on the medical staff of the National Institute of Allergy and Immunology at the NIH in Bethesda, and did his postdoctoral training at the Laboratory of Immunology. He joined the Johns Hopkins faculty in 1990 as a junior faculty member.

Dr. Schneck was the PI of a research project funded by a $10.3 million NIH grant—the largest basic immunology grant ever received by Johns Hopkins. He has been recognized by the Johns Hopkins Lymphoma SPORE with a Career Development Award.

...read more

Titles

  • Professor of Pathology
  • Professor of Oncology

Departments / Divisions

Centers & Institutes

Research & Publications

Research Summary

Dr. Schneck’s research focuses on the basic mechanisms that control immune responses. Specifically, he studies how cytotoxic T-cells, known as killer T cells—cells that help eliminate infections or cancers—get activated, recognize their targets and get turned off again. His team focuses on how to manipulate the immune system with the hopes of designing improved anti-cancer therapies by ramping up the immune system, or treating autoimmune disease and transplant patients with better immune system suppression.

Selected Publications

View all on PubMed

  1. Perica K, Bieler JG, Edidin M, Schneck J. Modulation of MHC binding by lateral association of TCR and coreceptor. Biophys J. 2012 Nov 7;103(9):1890-8. doi: 10.1016/j.bpj.2012.09.011. PMID: 23199917 
  2. Boyle S, Kolin DL, Bieler JG, Schneck JP, Wiseman PW, Edidin M. Quantum dot fluorescence characterizes the nanoscale organization of T cell receptors for antigen. Biophys J. 2011 Dec 7;101(11):L57-9. doi: 10.1016/j.bpj.2011.10.028. PMID: 22261075 
  3. Xiao Z, Mohamood AS, Uddin S, Gutfreund R, Nakata C, Marshall A, Kimura H, Caturegli P, Womer KL, Huang Y, Jie C, Chakravarti S, Schneck JP, Yagita H, Hamad AR. Inhibition of Fas ligand in NOD mice unmasks a protective role for IL-10 against insulitis development. Am J Pathol. 2011 Aug;179(2):725-32. doi: 10.1016/j.ajpath.2011.04.016. Epub 2011 Jun 15. PMID: 21718680 
  4. Chiu YL, Schneck JP, Oelke M. HLA-Ig based artificial antigen presenting cells for efficient ex vivo expansion of human CTL. J Vis Exp. 2011 Apr 11;(50). pii: 2801. doi: 10.3791/2801. PMID: 21505415 
  5. Webb TJ, Bieler JG, Schneck JP, Oelke M. Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells. J Immunol Methods. 2009 Jul 31;346(1-2):38-44. doi: 10.1016/j.jim.2009.05.003. Epub 2009 May 14. PMID: 19446558

de Melo AB, Nascimento EJ, Braga-Neto U, Dhalia R, Silva AM, Oelke M, Schneck JP, Sidney J, Sette A, Montenegro SM, Marques ET. T-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-1 and -II binding motifs. PLoS Negl Trop Dis, 7(1):Jan. 31, 2013 (Epub ahead of print).

Webb TJ, Li X, Giuntoli RL 2nd, Lopez PH, Heuser C, Schnaar RL, Tsuji M, Kurts C, OelkeM, Schneck JP. Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer. Cancer Res, 72(15):3744-52, 2012.

Lee JB, Oelke M, Ramachandra L, Canaday DH, Schneck JP. Decline of influenza-specific CD8+ T cell repertoire in healthy geriatric donors. Immun Ageing, 8(6):4-11, 2011.

Contact for Research Inquiries

Email me Phone: 410-614-4589

Academic Affiliations & Courses

Graduate Program Affiliation

Immunology
Pathobiology
Cellular and Molecular Medicine

Courses and Syllabi

  • Immunology (Course Director)

Activities & Honors

Honors

  • Career Development Award, Johns Hopkins Lymphoma SPORE
Is this you? Edit Profile
back to top button